EarningsQ2 2026 Earnings Report

Fate Therapeutics (F6T) Q2 2026 Earnings Report

1 Followers

DE:F6T Q2 2026 EPS Results

Actual EPS-€0.22

Consensus EPS-€0.24

Beat/MissBeat by +€0.02

One Year Ago EPS-€0.26

Actual Revenue€1.86M

Expected Revenue€1.20M

Beat/MissBeat by +€662.16K

YoY Revenue Growth+9.18%

QuarterQ2 2026

Date08/13/2026

TimeBefore Open

Conference CallThursday, August 13, 2026

DE:F6T Upcoming Earnings

Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 01, 2027	2026 (Q4)	- / -	-0.241	―
Oct 29, 2026	2026 (Q3)	-0.24 / -	-0.241	―
Aug 13, 2026	2026 (Q2)	-0.24 / -0.22	-0.259	13.79% (+0.04)
May 13, 2026	2026 (Q1)	-0.25 / -0.23	-0.286	18.75% (+0.05)
Feb 26, 2026	2025 (Q4)	-0.24 / -0.24	-0.393	38.64% (+0.15)
Nov 13, 2025	2025 (Q3)	-0.26 / -0.24	-0.357	32.50% (+0.12)
Aug 12, 2025	2025 (Q2)	-0.31 / -0.26	-0.294	12.12% (+0.04)
May 13, 2025	2025 (Q1)	-0.34 / -0.29	-0.419	31.91% (+0.13)
Mar 05, 2025	2024 (Q4)	-0.39 / -0.39	-0.402	2.22% (<+0.01)
Nov 12, 2024	2024 (Q3)	-0.37 / -0.36	-0.411	13.04% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed